Real-World Utilization of Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals-Reference-Cited by-同舟云学术

Real-World Utilization of Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals

Published:2021-04 Issue:4 Volume:23 Page:484-494
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

van de Ven Michiel^ORCID,Koffijberg Hendrik^ORCID,Retèl Valesca,Monkhorst Kim^ORCID,Smit Egbert,van Harten Wim,IJzerman Maarten^ORCID

Funder

ZonMw

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference39 articles.

1. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy;Chalela;J Thorac Dis,2017

2. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

3. Changing the therapeutic landscape in non-small cell lung cancers: the evolution of comprehensive molecular profiling improves access to therapy;Sabari;Curr Oncol Rep,2017

4. Current and future perspectives of liquid biopsies in genomics-driven oncology;Heitzer;Nat Rev Genet,2019

5. Precision diagnosis and treatment for advanced non–small-cell lung cancer;Reck;N Engl J Med,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review;Critical Reviews in Oncology/Hematology;2024-10

2. Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review;Value in Health;2024-09

3. Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience;Oncology and Therapy;2024-01-11

4. Dynamic Simulation Modeling to Analyze the Impact of Whole Genome Sequencing National Implementation Scenarios in Lung cancer on Time-to-Treatment, Costs and Patient Demand;2023-11-11

5. System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model;Expert Review of Pharmacoeconomics & Outcomes Research;2023-10-10